Cargando…
Desmin and CD31 immunolabeling for detecting venous invasion of the pancreatobiliary tract cancers
Although venous invasion (VI) is a poor prognostic factor for patients with pancreatobiliary tract cancers, its histopathologic characteristics have not been well described. We evaluated the patterns of VI and the added benefit provided by CD31, desmin, and dual CD31‒desmin immunolabeling for identi...
Autores principales: | Shin, Junyoung, Wood, Laura D., Hruban, Ralph H., Hong, Seung-Mo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703967/ https://www.ncbi.nlm.nih.gov/pubmed/33253282 http://dx.doi.org/10.1371/journal.pone.0242571 |
Ejemplares similares
-
An assessment of chromosomal alterations detected by fluorescence in situ hybridisation in pancreatobiliary tract malignancy
por: Pu, Xiaohong, et al.
Publicado: (2020) -
Cancerization of the Pancreatic Ducts: Demonstration of a Common and Under-recognized Process Using Immunolabeling of Paired Duct Lesions and Invasive Pancreatic Ductal Adenocarcinoma for p53 and Smad4 Expression
por: Hutchings, Danielle, et al.
Publicado: (2018) -
Molecular diagnosis of pancreatobiliary tract cancer by detecting mutations and methylation changes in bile samples
por: He, Shun, et al.
Publicado: (2022) -
Rivaroxaban versus Low-Molecular-Weight Heparin for Venous Thromboembolism in Gastrointestinal and Pancreatobiliary Cancer
por: Lee, Jang Ho, et al.
Publicado: (2019) -
Carcinoma of Pancreatobiliary Origin
por: Kohoutová, Darina, et al.
Publicado: (2020)